3.48
-0.34 (-8.9%)
-0.34 (-8.9%)
Upgrade to Real-Time
Afterhours (Closed)
Low
1.95
High
7.72
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Genprex Inc | GNPX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.34 | -8.9% | 3.48 | 19:56:45 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.86 | 3.22 | 3.88 | 3.40 | 3.82 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.42 | 3.48 | 0.06 | - | 1 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,352 | 1,979,440 | $ 3.51 | $ 6,942,560 | 1,789,143 | 1.95 - 7.72 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:42:46 | formt | 367 | $ 3.48 | USD |
Genprex Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 149.83M | 43.05M | 38.58M | $ - | $ - | -0.66 | -7.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Genprex News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GNPX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.21 | 4.38 | 3.22 | 4.01 | 623,036 | -0.73 | -17.34% |
| 1 Month | 4.95 | 5.00 | 3.22 | 4.38 | 957,939 | -1.47 | -29.7% |
| 3 Months | 4.3669 | 7.72 | 3.22 | 5.41 | 1,438,904 | -0.8869 | -20.31% |
| 6 Months | 3.68 | 7.72 | 2.84 | 4.72 | 1,313,068 | -0.20 | -5.43% |
| 1 Year | 2.05 | 7.72 | 1.95 | 3.91 | 1,594,032 | 1.43 | 69.76% |
| 3 Years | 4.00 | 19.4499 | 0.231 | 3.44 | 1,300,006 | -0.52 | -13.0% |
| 5 Years | 4.69 | 19.4499 | 0.231 | 3.44 | 1,276,161 | -1.21 | -25.8% |
Genprex Description
| Genprex Inc is a clinical stage gene therapy company. It is engaged in developing a new approach to treating cancer based on its novel proprietary technology platform, including initial product candidate, Oncoprex immunogene therapy. Oncoprex, which has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis in cancer cells and modulates the immune response against cancer cells. |
